Croatian
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

MabCampath (alemtuzumab) - L01XC04

Updated on site: 08-Oct-2017

Naziv lijekaMabCampath
ATK šifraL01XC04
Tvaralemtuzumab
ProizvođačGenzyme Europe B.V.

What is MabCampath?

This is a summary of the European public assessment report (EPAR) for MabCampath. It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for MabCampath.

What is MabCampath used for?

MabCampath is a concentrate that is made up noi to a solution for infusion (drip into a vein). It contains the active substanceproductalemtuzumab (10 mg/ml or 30 mg/ml).

MabCampath is used to treat patients with B-cell chronic lymphocytic leukaemia (B-CLL), a cancer of a type of white blood cell called B lymphocytes. MabCampath is used in patients for whom treatment combinations including fluda abine (another medicine used in leukaemia) are not appropriate.

MedicinalThe medicine can on y be obtained with a prescription.

How is M bC mpath used?

MabCampath treatment should be supervised by a doctor experienced in the use of cancer treatments. Pat ents should be given steroids, an antihistamine and a painkiller before the first dose and before any

rease in dose. They should also receive antibiotics and antiviral medicines during and after

treatment.

Komentari

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
  • Pomoć
  • Get it on Google Play
  • O nama
  • Info on site by:

  • Presented by RXed.eu

  • 27558

    popisanih lijekova na recept